Journal Article

Hepatocellular proliferation in response to a peroxisome proliferator does not require TNFα signaling

Steven P. Anderson, Corrie S. Dunn, Russell C. Cattley and J.Christopher Corton

in Carcinogenesis

Volume 22, issue 11, pages 1843-1851
Published in print November 2001 | ISSN: 0143-3334
Published online November 2001 | e-ISSN: 1460-2180 | DOI:
Hepatocellular proliferation in response to a peroxisome proliferator does not require TNFα signaling

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics


Show Summary Details


Rodents exposed to peroxisome proliferator xenobiotics respond with marked increases in hepatocellular replication and growth that results in tumor formation. Recently, tumor necrosis factor-α (TNFα) was proposed as the central mediator of this maladaptive response. To define the role of TNFα signaling in hepatocellular growth induced by peroxisome proliferators we administered three daily gavage doses of the potent peroxisome proliferator, Wy-14 643, to mice nullizygous for TNF-receptor I (TNFR1), TNFR2, or both receptors. We demonstrate here that regardless of genotype the mice responded with almost identical increases in liver to body weight ratios and hepatocyte proliferation. Lacking evidence that TNFα signaling mediates these effects, we then examined the possible contribution of alternative cytokine pathways. Semi-quantitative, reverse transcriptase polymerase chain reaction analysis revealed that wild type mice acutely exposed to Wy-14 643 had increased hepatic expression of Il1β, Il1r1, Hnf4, and Stat3 genes. Moreover, hepatic adenomas from mice chronically exposed to Wy-14 643 had increased expression of Il1β, Il1r1, Il6, and Pparγ1. Expression of Il1α, Tnfα, Tnfr1, Tnfr2, Pparα, or C/ebpα was not altered by acute Wy-14 643 exposure or in adenomas induced by Wy-14643. These data suggest that the hepatic mitogenesis and carcinogenesis associated with peroxisome proliferator exposure is not mediated via TNFα but instead may involve an alternative pathway requiring IL1β and IL6.

Keywords: APP, acute-phase proteins; C/ebp, CCAAT enhancer binding protein; Hnf, hepatic nuclear factor; Il, interleukin; LPS, lipopolysaccharide; NfκB, nuclear factor kappa B; PP, peroxisome proliferator; Ppar, Peroxisome proliferator-activated receptor; RT-PCR, reverse transcriptase-polymerase chain reaction; Stat, signal transducer of activated transcription; Tgf, tumor growth factor; Tnf, tumor necrosis factor; WY, Wy-14 643

Journal Article.  7273 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.